Blockade of Epidermal Growth Factor Receptor Signaling on Tumor Cells and Tumor-Associated Endothelial Cells for Therapy of Human Carcinomas
- 1 September 2002
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 161 (3) , 929-938
- https://doi.org/10.1016/s0002-9440(10)64253-8
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- EGF receptorThe International Journal of Biochemistry & Cell Biology, 1999
- Vascular Endothelial Growth Factor (VEGF)-Mediated Angiogenesis Is Associated with Enhanced Endothelial Cell Survival and Induction of Bcl-2 ExpressionPublished by Elsevier ,1999
- Antitumor Activity of Combined Blockade of Epidermal Growth Factor Receptor and Protein Kinase AJNCI Journal of the National Cancer Institute, 1996
- Modulation of the Organ Microenvironment for Treatment of Cancer MetastasisJNCI Journal of the National Cancer Institute, 1995
- Both v-Ha-Ras and v-Raf Stimulate Expression of the Vascular Endothelial Growth Factor in NIH 3T3 CellsPublished by Elsevier ,1995
- Identification of EGF as an angiogenic factor present in conditioned medium from human salivary gland adenocarcinoma cell clones with varying degrees of metastatic potentialCancer Letters, 1994
- The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1Nature, 1993
- In vivo selection of human renal cell carcinoma cells with high metastatic potential in nude miceClinical & Experimental Metastasis, 1989
- Transforming Growth Factor-α: a More Potent Angiogenic Mediator than Epidermal Growth FactorScience, 1986
- THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST.The Lancet, 1889